Jacob Witten (J Witten)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Pseudomonas Aeruginosa

Top Venues

Scientific reports

Biomacromolecules

ACS biomaterials science & engineering

Nature nanotechnology

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Massachusetts Institute of Technology Sep 01 2014

United States

PHD :: Computational and Systems Biology

Publications

Allen Yujie Jiang, Jacob Witten, Idris O Raji, Feyisayo Eweje, Corina MacIsaac, Sabrina Meng, Favour A Oladimeji, Yizong Hu, Rajith Singh Manan, Robert S Langer, Daniel G Anderson
Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nature nanotechnology (2023)
Jacob Witten, Tahoura Samad, Katharina Ribbeck
Molecular Characterization of Mucus Binding. Biomacromolecules 20 (4) (2019)
Tahoura Samad, Julia Y Co, Jacob Witten, Katharina Ribbeck
Mucus and Mucin Environments Reduce the Efficacy of Polymyxin and Fluoroquinolone Antibiotics against Pseudomonas aeruginosa. ACS biomaterials science & engineering 5 (3) (2019)
K B Smith-Dupont, C E Wagner, Jacob Witten, K Conroy, H Rudoltz, K Pagidas, V Snegovskikh, M House, K Ribbeck
Probing the potential of mucus permeability to signify preterm birth risk. Scientific reports 7 (1) (2017)